Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Merck withdraws arthritis drug worldwide.

× No keyword cloud information.

2 in total

Review 1. Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors: D Mukherjee; S E Nissen; E J Topol
Journal: JAMA Date: 2001 Aug 22-29 Impact factor: 56.272

2. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors: C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal: N Engl J Med Date: 2000-11-23 Impact factor: 91.245

2 in total

15 in total

1. Confronting the Christmas of our health care discontent.

Authors: Steven Lewis
Journal: CMAJ Date: 2004-12-07 Impact factor: 8.262

2. Patients' interests: paramount in randomised trials.

Authors: Tony Stevens; Roger Wilson
Journal: BMJ Date: 2005-01-01

Review 3. Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors: Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal: Drug Saf Date: 2011-04-01 Impact factor: 5.606

4. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project.

Authors: Paul Avillach; Jean-Charles Dufour; Gayo Diallo; Francesco Salvo; Michel Joubert; Frantz Thiessard; Fleur Mougin; Gianluca Trifirò; Annie Fourrier-Réglat; Antoine Pariente; Marius Fieschi
Journal: J Am Med Inform Assoc Date: 2012-11-29 Impact factor: 4.497

Review 5. Reporting bias in medical research - a narrative review.

Authors: Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal: Trials Date: 2010-04-13 Impact factor: 2.279

6. Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.

Authors: Yu Yang; Xiaofeng Zhou; Shuangqing Gao; Hongbo Lin; Yanming Xie; Yuji Feng; Kui Huang; Siyan Zhan
Journal: Drug Saf Date: 2018-01 Impact factor: 5.606

7. Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme.

Authors: Mira Harrison-Woolrych; Peter Herbison; Rachael McLean; Janelle Ashton; Jim Slattery
Journal: Drug Saf Date: 2005 Impact factor: 5.606

Merck withdraws arthritis drug worldwide.